Reinfection Rates Following Cardiovascular Implantable Electronic Device Reimplementation Post-device Primary Infection

Author:

Anyagwa Onyekachi1,Rampurawala Fatema2,Alchaar Lama1,Gharib Taymaa1,Ravuri Miyukta1,Fatima Kulsum3,Mishra Namrata1,Bhatt Rutvi4,Essakkiraj Maha1,Tak Rajeeka1,Kassem Maha1

Affiliation:

1. New Vision University, Tbilisi, Georgia

2. David Tvildiani Medical University, Tbilisi, Georgia

3. Tbilisi State Medical University, Georgia

4. Caucasus International University, Tbilisi, Georgia

Abstract

Cardiovascular implantable electronic device (CIED) infections have become an increasing problem around the world, affecting one in 20 patients within 3 years of device implementation. Prevention of reinfection following CIED reimplantation is a prominent challenge. One of the most difficult aspects of managing CIED infections is the complexities of their diagnosis: with the complexities of many infections, timely and correct diagnosis becomes complicated, frequently causing delays in commencing proper therapy, and worsening disease severity. As patients receiving CIED therapy are now older, and possess significant comorbidities, they are at a higher risk of infection. The American Heart Association (AHA) has issued a statement to educate clinicians about CIED infections, and the required care for those with suspected or diagnosed infections. To prevent an infection from spreading, it is important to isolate the causative pathogen and perform testing for susceptibility, which is required for crucial choices, including routes and duration of antimicrobial therapy. This review aims to serve as a valuable resource for healthcare professionals, by synthesising current knowledge and best practices; and providing insights into preventive measures, diagnostic challenges, therapeutic strategies, and evidence-based approaches to diagnose and improve the management of CIED infections in an ageing and medically complex patient population.

Publisher

European Medical Group

Reference41 articles.

1. Physiopedia. Cardiac implantable electronic devices (CIEDs). Available at: https://www.physio-pedia.com/Cardiac_Implantable_Electronic_Devices_(CIEDs). Last accessed: 17 January 2024.

2. Baher A, Valderrabano M. Management of ventricular tachycardia in heart failure. Methodist DeBakey Cardiovasc J. 2013;9(1):20-5.

3. Abi-Samra FM. Cardiac implantable electrical devices: bioethics and management issues near the end of life. Ochsner J. 2011;11(4):342-7.

4. Richardson CJ et al. Surgical techniques, complications, and long-term health effects of cardiac implantable electronic devices. Cureus. 2021;13(1):e13001.

5. Cleveland Clinic. Cardiac implantable electronic device replacement. Available at: https://my.clevelandclinic.org/health/treatments/16837-cardiac-implantable-electronic-device-replacement. Last accessed: 5 September 2023.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3